Nanoscale Cancer Diagnostics
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
450
NCT03797053
Ex Vivo Expansion of Circulating Tumor Cells as a Model for Cancer Predictive Pharmacology
Phase: N/A
Role: Collaborator
Start: Apr 6, 2015
Completion: Jun 30, 2019
Loading map...